Factors Affecting Drug Shortage in Aseer Hospitals
Main Article Content
Abstract
Background: drug shortage is a critical with severe negative impacts on patients’ outcome. It is a multifactorial problem in the world leading to increased cost of health, poor treatment outcomes and unnecessary patient referrals.
Purpose: this study sought to examine the various causes of drug shortage in Aseer Hospital as a foundational investigation for improvement recommendations.
To explore the factors affecting drug shortage and the magnitude of every factor’s influence in drug shortage.
Material and methods: this study applied a cross sectional descriptive research design of the quantitative methodology. A questionnaire was electronically sent to the 177 sample for completion. The data was then analyzed using the descriptive statistics of Statistical Package for Social Services (SPSS), version 26.
Results: a total of 177 questionnaires were completed. Out of the total sample, male gender dominated by 74.6% (n=132) while 25% were females. The dominant age group was (30-39) years old and most of the sampled pharmacists had bachelors in pharmacy 46.9% (n=83). In terms of experience at work, those who had worked for (5-10) years were the majority. Amongst the variables that contribute to drug shortage, this study found regulation and legislative processes (0.80=77.06%) as the major cause while imbalance between the supply and demand was the least cause (64.3%). There were other factors that contributed to drug shortage such as manufacturing problems (69.80%), drug distribution problems (69.0%) and human factor (65.57%).
Conclusion: the study findings are in agreement with most of the previous scholarly findings that cited regulation and legislative process as one of the most causes of drug shortage.
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Al-Aqeel, S. A., Al-Salloum, H. F., Abanmy, N. O., & Al-Shamrani, A. A. (2010). Undispensed prescriptions due to drug unavailability at a teaching hospital in Saudi Arabia. International Journal of Health Research, 3(4), 213-216.
II. AlRuthia, Y. S., AlKofide, H., AlAjmi, R., Balkhi, B., Alghamdi, A., AlNasser, A., Alayed, A., Alshammari, M., Alsuhaibani, D., & Alathbah, A. (2017). Drug shortages in large hospitals in Riyadh: a cross-sectional study. Annals of Saudi medicine, 37(5), 375–385. https://doi.org/10.5144/0256-4947.2017.375
III. Alruthia, Y. S., Alwhaibi, M., Alotaibi, M. F., Asiri, S. A., Alghamdi, B. M., Almuaythir, G. S., ... & Alshamsan, A. (2018). Drug shortages in Saudi Arabia: Root causes and recommendations. Saudi Pharmaceutical Journal, 26(7), 947-951.
IV. Alruthia, Y. S., Alwhaibi, M., Alotaibi, M. F., Asiri, S. A., Alghamdi, B. M., Almuaythir, G. S., Alsharif, W. R., Alrasheed, H. H., Alswayeh, Y. A., Alotaibi, A. J., Almeshal, M., Aldekhail, S. N., Alhusaini, A., Alrashed, S. A., Alrumaih, A. M., Dahhas, M. A., Alghamdi, M. A., Aleheidib, M. S., Alhaidari, M. H., Alharbi, J. A., … Alshamsan, A. (2018). Drug shortages in Saudi Arabia: Root causes and recommendations. Saudi pharmaceutical journal : SPJ: the official publication of the Saudi Pharmaceutical Society, 26(7), 947–951. https://doi.org/10.1016/j.jsps.2018.05.002
V. Alsheikh, M., Seoane-Vazquez, E., Rittenhouse, B., Fox, E. R., & Fanikos, J. (2016). A Comparison of Drug Shortages in the Hospital Setting in the United States and Saudi Arabia: An Exploratory Analysis. Hospital pharmacy, 51(5), 370–375. https://doi.org/10.1310/hpj5105-370
VI. American Society of Health System Pharmacists (2020). Drug Shortages Statistics. https://www.ashp.org/Drug-Shortages/Shortage-Resources/Drug-Shortages-Statistics?loginreturnUrl=SSOCheckOnly.
VII. American Society of Health-System Pharmacists (2011). Drug Shortages Summit Report. Available at: www.ashp.org/drugshortages/summitreport.
VIII. ASHP Expert Panel on Drug Product Shortages, Fox, E. R., Birt, A., James, K. B., Kokko, H., Salverson, S., & Soflin, D. L. (2009). ASHP Guidelines on Managing Drug Product: AJHP : official journal of the American Society of Health-System Pharmacists, 66(15), 1399–1406. https://doi.org/10.2146/ajhp090026
IX. Bogaert, P., Bochenek, T., Prokop, A., & Pilc, A. (2015). A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives. PloS one, 10(5), e0125691. https://doi.org/10.1371/journal.pone.0125691
X. De Weerdt, E., Simoens, S., Hombroeckx, L., Casteels, M., & Huys, I. (2015). Causes of drug shortages in the legal pharmaceutical framework. Regulatory toxicology and pharmacology : RTP, 71(2), 251–258. https://doi.org/10.1016/j.yrtph.2015.01.005
XI. Dill, S., & Ahn, J. (2014). Drug shortages in developed countries--reasons, therapeutic consequences, and handling. European journal of clinical pharmacology, 70(12), 1405–1412. https://doi.org/10.1007/s00228-014-1747-1
XII. Fox, E. R., & McLaughlin, M. M. (2018). ASHP guidelines on managing drug product shortages. American Journal of Health-System Pharmacy, 75(21), 1742-1750.
XIII. Hedman L. (2016). Global Approaches to Addressing Shortages of Essential Medicines in Health Systems. WHO Drug Inf. 30, 180.
XIV. Jenzer, H., Sadeghi, L., Maag, P., Scheidegger-Balmer, F., Uhlmann, K., & Groesser, S. (2019). The European medicines shortages research network and its mission to strategically debug disrupted pharmaceutical supply chains. Pharmaceutical Supply Chains-Medicines Shortages, 1-22.
XV. Mazer‐Amirshahi, M., Pourmand, A., Singer, S., Pines, J. M., & van den Anker, J. (2014). Critical drug shortages: implications for emergency medicine. Academic Emergency Medicine, 21(6), 704-711. https://doi.org/10.1111/acem.12389
XVI. McLaughlin, M. M., Sutton, S. H., Jensen, A. O., & Esterly, J. S. (2017). Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage Management. Infectious diseases and therapy, 6(2), 259–264.
https://doi.org/10.1007/s40121-017-0157-y
XVII. Pauwels, K., Simoens, S., Casteels, M., & Huys, I. (2015). Insights into European drug shortages: a survey of hospital pharmacists. PloS one, 10(3), e0119322. https://doi.org/10.1371/journal.pone.0119322
XVIII. Phuong, J. M., Penm, J., Chaar, B., Oldfield, L. D., & Moles, R. (2019). The impacts of medication shortages on patient outcomes: A scoping review. PloS one, 14(5), e0215837.
https://doi.org/10.1371/journal.pone.0215837
XIX. Rider, A. E., Templet, D. J., Daley, M. J., Shuman, C., & Smith, L. V. (2013). Clinical dilemmas and a review of strategies to manage drug shortages. Journal of pharmacy practice, 26(3), 183–191. https://doi.org/10.1177/0897190013482332
XX. Rinaldi, F., de Denus, S., Nguyen, A., Nattel, S., & Bussières, J. F. (2017). Drug Shortages: Patients and Health Care Providers Are All Drawing the Short Straw. The Canadian journal of cardiology, 33(2), 283–286. https://doi.org/10.1016/j.cjca.2016.08.010
XXI. Schwartzberg, E., Ainbinder, D., Vishkauzan, A., & Gamzu, R. (2017). Drug shortages in Israel: regulatory perspectives, challenges and solutions. Israel journal of health policy research, 6, 17. https://doi.org/10.1186/s13584-017-0140-9
XXII. Setayesh, S., & Mackey, T. K. (2016). Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy. Globalization and health, 12(1), 31. https://doi.org/10.1186/s12992-016-0168-6
XXIII. Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., Hu, S., Babar, Z. U., Fang, Y., & Yang, C. (2021). Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in pharmacology, 12, 693426. https://doi.org/10.3389/fphar.2021.693426
XXIV. Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., Hu, S., Babar, Z. U., Fang, Y., & Yang, C. (2021). Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in pharmacology, 12, 693426. https://doi.org/10.3389/fphar.2021.693426
XXV. Videau, M., Chemali, L., Stucki, C., Saavedra-Mitjans, M., Largana, S., Guerin, A., Bonnabry, P., Delhauteur, B., Van Hees, T., Lebel, D., & Bussières, J. F. (2019).